<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36949299</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment.</ArticleTitle><Pagination><StartPage>2795</StartPage><EndPage>2802</EndPage><MedlinePgn>2795-2802</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-023-06751-7</ELocationID><Abstract><AbstractText>Cognitive impairment (CI) is common in amyotrophic lateral sclerosis (ALS): a keystone is identifying factors that could potentially modify the CI course. In recent years, vitamin D is becoming a potential modificatory factor for CI in many neurological disorders. This study aimed to highlight if vitamin D deficiency correlated with CI and clinical features in a cohort of ALS patients. We included 55 ALS patients with a neuropsychological evaluation (classified with the Strong Criteria) and a vitamin D dosage at the diagnosis. We also reviewed medical records and completed data for medical history, physical and neurological examination, and functional scales. At the diagnosis, 30 patients (54%) had CI. Most patients (82%) displayed low vitamin D levels (19.87 &#xb1; 9.80 ng/ml). Comparing the vitamin D level between patients with and without CI, we observed significantly lower values in the first group (15.8 &#xb1; 8.2 vs. 22.0 &#xb1; 9.7 ng/ml, p: 0.04). In the spinal female subgroup (n = 15), we found an inverse correlation between vitamin D and bizarreness score in the cognitive estimates test (r = 0.58; p: 0.04) and a positive correlation with the Corrected Raven's Standard Progressive Matrices (r = 0.53, p: 0.04). Conversely, in the bulbar female group, we observed a correlation with the corrected direct span (r = 0.84, p: 0.03). With the log-rank survival analysis, we found that the patients with vitamin D &lt; 10 ng/ml had a shorter disease duration (Chi: 5.78, p: 0.02). Our results indicate that levels of vitamin D can influence the cognitive status of people living with ALS and that severe deficits might be an adverse prognostic survival factor.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Marchi</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0197-1880</Identifier><AffiliationInfo><Affiliation>ALS Centre, Neurology Unit, Department of Translational Medicine, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy. fabiola.demarchi@uniupo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saraceno</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ALS Centre, Neurology Unit, Department of Translational Medicine, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarnelli</LastName><ForeName>Maria Francesca</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>ALS Centre, Neurology Unit, Department of Translational Medicine, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virgilio</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Translational Medicine, Maggiore Della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantello</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Translational Medicine, Maggiore Della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ALS Centre, Neurology Unit, Department of Translational Medicine, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014808" MajorTopicYN="Y">Vitamin D Deficiency</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36949299</ArticleId><ArticleId IdType="pmc">PMC10345066</ArticleId><ArticleId IdType="doi">10.1007/s10072-023-06751-7</ArticleId><ArticleId IdType="pii">10.1007/s10072-023-06751-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, Manera U, D&#x2019;Ovidio F, Vasta R, et al. ALS phenotype is influenced by age, sex, and genetics: a population-based study. Neurology. 2020;94(8):e802&#x2013;e810.</Citation><ArticleIdList><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SA, Fang T, De Marchi F, Neel D, Van Weehaeghe D, Berry JD, et al. Pharmacotherapy for amyotrophic lateral sclerosis: a review of approved and upcoming agents. Drugs. 2022;82(13):1367&#x2013;1388.</Citation><ArticleIdList><ArticleId IdType="pubmed">36121612</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400(10360):1363&#x2013;1380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10089700</ArticleId><ArticleId IdType="pubmed">36116464</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83(1):102&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">21836033</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeldman E, Raaphorst J, Twennaar MK, de Visser M, Schmand BA, de Haan RJ. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2016;87(6):611&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">26283685</ArticleId></ArticleIdList></Reference><Reference><Citation>Caga J, Hsieh S, Highton-Williamson E, Zoing MC, Ramsey E, Devenney E, et al. Apathy and its impact on patient outcome in amyotrophic lateral sclerosis. J Neurol. 2018;265(1):187&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">29189922</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3&#x2013;4):153&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Carrarini C, De Martino A, Diamanti L, Fasano A, Lupica A, et al. Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it? Neurol Sci. 2021;42(6):2211&#x2013;2222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8159827</ArticleId><ArticleId IdType="pubmed">33772353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16563471</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xfc;fer K, Racz A, Lin GC, Barsony J. Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors. J Biol Chem. 2000;275(52):41114&#x2013;41123.</Citation><ArticleIdList><ArticleId IdType="pubmed">11001945</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF. Mayo Clinic Proceedings. Elsevier; 2015. Vitamin D is not as toxic as was once thought: a historical and an up-to-date perspective; pp. 561&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">25939933</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello M, Landel V, Lacassagne E, Baranger K, Annweiler C, F&#xe9;ron F, et al. Vitamin D improves neurogenesis and cognition in a mouse model of Alzheimer&#x2019;s disease. Mol Neurobiol. 2018;55(8):6463&#x2013;6479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6061182</ArticleId><ArticleId IdType="pubmed">29318446</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti R, Morelli ME, Caruso P. Vitamin D in neurological diseases: a rationale for a pathogenic impact. Int J Mol Sci. 2018;19(8):2245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6121649</ArticleId><ArticleId IdType="pubmed">30065237</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese F, Costantino MF, Luzi G, Di Marino S, Giordano P, Monitillo F. Vitamin D and cardiovascular disease risk. A literature overview. Mol Biol Rep. 2022;49(9):8925&#x2013;8942.</Citation><ArticleIdList><ArticleId IdType="pubmed">35364717</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezza T, Muscogiuri G, Sorice GP, Prioletta A, Salomone E, Pontecorvi A, et al. Vitamin D deficiency: a new risk factor for type 2 diabetes. Ann Nutr Metab. 2012;61(4):337&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">23208163</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X, McGrath JJ, Burne THJ, Eyles DW. Vitamin D and schizophrenia: 20 years on. Mol Psychiatry. 2021;26(7):2708&#x2013;2720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505257</ArticleId><ArticleId IdType="pubmed">33500553</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuano R, Marchese F, Sica R, Capuano E, Manilia M, Iannone AG, et al. Epidemiologic data of vitamin D deficiency and its implication in cardio-cerebrovascular risk in a Southern Italian population. J Nutr Metab. 2021;2021:5550222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8205572</ArticleId><ArticleId IdType="pubmed">34211785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanznaster D, Bejan-Angoulvant T, Gand&#xed;a J, Blasco H, Corcia P. Is there a role for vitamin D in amyotrophic lateral sclerosis? A systematic review and meta-analysis. Front Neurol. 2020;11:697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7411408</ArticleId><ArticleId IdType="pubmed">32849187</ArticleId></ArticleIdList></Reference><Reference><Citation>Libonati L, Onesti E, Gori MC, Ceccanti M, Cambieri C, Fabbri A, et al. Vitamin D in amyotrophic lateral sclerosis. Funct Neurol. 2017;32(1):35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5505528</ArticleId><ArticleId IdType="pubmed">28380322</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Madji Hounoum B, Dufour-Rainfray D, Patin F, Maillot F, Beltran S, et al. Vitamin D is not a protective factor in ALS. CNS Neurosci Ther. 2015;21(8):651&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6495158</ArticleId><ArticleId IdType="pubmed">26096806</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Macklin EA, Karam C, Yu H, Gonterman F, Fetterman KA, et al. Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosis. Muscle Nerve. 2017;56(4):726&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pubmed">28044349</ArticleId></ArticleIdList></Reference><Reference><Citation>Camu W, Tremblier B, Plassot C, Alphandery S, Salsac C, Pageot N, et al. Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35(5):1198&#x2013;1205.</Citation><ArticleIdList><ArticleId IdType="pubmed">24378089</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Park J-S, Oh K-W, Oh S, Park H-M, Kim SH. Vitamin D levels are not predictors of survival in a clinic population of patients with ALS. J Neurol Sci. 2016;367:83&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">27423568</ArticleId></ArticleIdList></Reference><Reference><Citation>Karam C, Barrett MJ, Imperato T, MacGowan DJL, Scelsa S. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis. J Clin Neurosci. 2013;20(11):1550&#x2013;1553.</Citation><ArticleIdList><ArticleId IdType="pubmed">23815870</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar-Navarro SG, Mimenza-Alvarado AJ, Jim&#xe9;nez-Castillo GA, Bracho-Vela LA, Yeverino-Castro SG, &#xc1;vila-Funes JA. Association of vitamin D with mild cognitive impairment and Alzheimer&#x2019;s dementia in older Mexican adults. Rev Investig cl&#xed;nica. 2019;71(6):381&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">31823966</ArticleId></ArticleIdList></Reference><Reference><Citation>Golimstok A, Berrios W, Fernandez M, Quintana MO, Zaifrani L, Bonifacio A, et al. Vitamin D and progression in mild cognitive impairment (MCI) J Neurol Sci. 2015;357:e126.</Citation></Reference><Reference><Citation>Virgilio E, Vecchio D, Crespi I, Barbero P, Caloni B, Naldi P, et al. Serum vitamin D as a marker of impaired information processing speed and early disability in multiple sclerosis patients. Brain Sci. 2021;11(11):1521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8615879</ArticleId><ArticleId IdType="pubmed">34827520</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Al-Chalabi A, Filippi M, Hardiman O, Kaji R, Meininger V, et al. The El Escorial criteria: strengths and weaknesses. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(1&#x2013;2):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25482030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Miller RG, Moore DH. ALSFRS-R. Amyotroph Lateral Scler Other Mot Neuron Disord. 2004;5(sup1):90&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">15512883</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1&#x2013;2):13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci. 2008;275(1&#x2013;2):69&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">18721928</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelune GJ, Bornstein RA, Prifitera A. Advances in psychological assessment. Springer; 1990. The Wechsler memory scale&#x2014;revised; pp. 65&#x2013;99.</Citation></Reference><Reference><Citation>Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55(11):1621&#x2013;1626.</Citation><ArticleIdList><ArticleId IdType="pubmed">11113214</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E. Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci. 1996;17(4):305&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">8915764</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Sala S, MacPherson SE, Phillips LH, Sacco L, Spinnler H. How many camels are there in Italy? Cognitive estimates standardised on the Italian population. Neurol Sci. 2003;24(1):10&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">12754651</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G. Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital J Neurol Sci. 1987;8(6):537&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">3429213</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainland BJ, Shulman KI. Cognitive screening instruments. Springer; 2013. Clock drawing test; pp. 79&#x2013;109.</Citation></Reference><Reference><Citation>Basso A, Capitani E, Laiacona M. Raven&#x2019;s coloured progressive matrices: normative values on 305 adult normal controls. Funct Neurol. 1987;2(2):189&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">3666548</ArticleId></ArticleIdList></Reference><Reference><Citation>Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia. 1967;5(2):135&#x2013;140.</Citation></Reference><Reference><Citation>Cesareo R, Attanasio R, Caputo M, Castello R, Chiodini I, Falchetti A, et al. Italian chapter of the American Association of Clinical Endocrinologists (AACE) position statement: Clinical management of vitamin D deficiency in adults. Nutrients. 2018;10(5):546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5986426</ArticleId><ArticleId IdType="pubmed">29702603</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavraki E, Ioannidis P, Tripsianis G, Gioka T, Kolousi M, Vadikolias K. Vitamin D in mild cognitive impairment and Alzheimer&#x2019;s disease. A study in older Greek adults. Hippokratia. 2020;24(3):120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8256783</ArticleId><ArticleId IdType="pubmed">34239289</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan S, Taimuri U, Basnan SA, Ai-Orabi WK, Awadallah A, Almowald F, et al. Low vitamin D and its association with cognitive impairment and dementia. J Aging Res. 2020;2020:6097820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7210535</ArticleId><ArticleId IdType="pubmed">32399297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleeman I, Aspray T, Lawson R, Coleman S, Duncan G, Khoo TK, et al. The role of vitamin D in disease progression in early Parkinson&#x2019;s disease. J Parkinsons Dis. 2017;7(4):669&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5676984</ArticleId><ArticleId IdType="pubmed">28984616</ArticleId></ArticleIdList></Reference><Reference><Citation>Barichella M, Garr&#xec; F, Caronni S, Bolliri C, Zocchi L, Macchione MC, et al. Vitamin D status and Parkinson&#x2019;s disease. Brain Sci. 2022;12(6):790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9221008</ArticleId><ArticleId IdType="pubmed">35741675</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangelo G, Raimo S, Erro R, Picillo M, Amboni M, Pellecchia MT, et al. Vitamin D as a possible biomarker of mild cognitive impairment in parkinsonians. Aging Ment Health. 2021;25(11):1998&#x2013;2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">33111573</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia J, Hu J, Huo X, Miao R, Zhang Y, Ma F. Effects of vitamin D supplementation on cognitive function and blood A&#x3b2;-related biomarkers in older adults with Alzheimer&#x2019;s disease: a randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2019;90(12):1347&#x2013;1352.</Citation><ArticleIdList><ArticleId IdType="pubmed">31296588</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Wang H, Xiong Y, Chen C, Duan K, Jia J, et al. Vitamin D supplementation improves cognitive function through reducing oxidative stress regulated by telomere length in older adults with mild cognitive impairment: a 12-month randomized controlled trial. J Alzheimer&#x2019;s Dis. 2020;78(4):1509&#x2013;1518.</Citation><ArticleIdList><ArticleId IdType="pubmed">33164936</ArticleId></ArticleIdList></Reference><Reference><Citation>Juntas-Morales R, Pageot N, Marin G, Dupuy A-M, Alphandery S, Labar L, et al. Low 25OH vitamin D blood levels are independently associated with higher amyotrophic lateral sclerosis severity scores: results from a prospective study. Front Neurol. 2020;11:363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272711</ArticleId><ArticleId IdType="pubmed">32547467</ArticleId></ArticleIdList></Reference><Reference><Citation>Manera U, Peotta L, Iazzolino B, Canosa A, Vasta R, Palumbo F, et al. The characteristics of cognitive impairment in ALS patients depend on the lateralization of motor damage. Brain Sci. 2020;10(9):650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7563934</ArticleId><ArticleId IdType="pubmed">32961718</ArticleId></ArticleIdList></Reference><Reference><Citation>Arosio B, Guerini FR, Costa AS, Dicitore A, Ferri E, Mari D, et al. Vitamin D receptor polymorphisms in sex-frailty paradox. Nutrients. 2020;12(9):2714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7551757</ArticleId><ArticleId IdType="pubmed">32899460</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1&#x3b1;-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">15589699</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland JP, Zhou A, Hypp&#xf6;nen E. Vitamin D deficiency increases mortality risk in the UK Biobank: a nonlinear mendelian randomization study. Ann Intern Med. 2022;175(11):1552&#x2013;1559.</Citation><ArticleIdList><ArticleId IdType="pubmed">36279545</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>